← back to search

Yuxin Luo

Hebei Medical University · CN
Area of research
Genetics · Epidemiology
Research interest
Research interests include Inflammatory Bowel Disease, Liver Disease Diagnosis and Treatment, Osteoarthritis Treatment and Mechanisms, and Helicobacter pylori-related gastroenterology studies.
h-index
10
citations
365
works
40
NIH funding
primary concept
email

Recent publications

[Clinical features of ulcerative colitis in patients with small intestinal bacterial overgrowth].
PubMed 2025cited by 0position: middledoi
TL1A Promotes Fibrogenesis in Colonic Fibroblasts via the TGF-β1/Smad3 Signaling Pathway
Current Medical Science 2024cited by 10position: middledoi
Exosomal long non-coding RNA AU020206 alleviates macrophage pyroptosis in atherosclerosis by suppressing CEBPB-mediated NLRP3 transcription
Experimental Cell Research 2024cited by 10position: middledoi
TL1A promotes metastasis and EMT process of colorectal cancer
Heliyon 2024cited by 9position: middledoi
Proteinase-Activated Receptor 1 Inhibition Alleviates Intestinal Fibrosis in Mice with Chronic Colitis
Research Square 2024cited by 0position: middledoi
Exosomes Derived from Mesenchymal Stem Cells Ameliorate the Progression of Atherosclerosis in ApoE−/− Mice via FENDRR
Cardiovascular Toxicology 2022cited by 27position: middledoi
<scp>CCN6</scp>improves hepatic steatosis, inflammation, and fibrosis in non‐alcoholic steatohepatitis
Liver International 2022cited by 13position: middledoi
Association between MHR and MAFLD: A Single-center Retrospective Study
Research Square 2022cited by 0position: middledoi
A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6
Stem Cell Research & Therapy 2021cited by 157position: middledoi
TNF‐Like Ligand 1 Aberrance Aggravates Nonalcoholic Steatohepatitis via M1 Macrophage Polarization
Oxidative Medicine and Cellular Longevity 2021cited by 18position: firstdoi
Tumor necrosis factor ligand-related molecule 1A affects the intestinal mucosal barrier function by promoting Th9/interleukin-9 expression
Journal of International Medical Research 2020cited by 7position: middledoi
[Ulcerative colitis complicated with Listeria infection and meningoencephalitis: a case report].
PubMed 2020cited by 1position: middledoi
Overexpression of Tumor Necrosis Factor-Like Ligand 1 A in Myeloid Cells Aggravates Liver Fibrosis in Mice
Journal of Immunology Research 2019cited by 22position: middledoi
TL1A modulates the severity of colitis by promoting Th9 differentiation and IL-9 secretion
Life Sciences 2019cited by 18position: middledoi
MicroRNA-142-5p facilitates the pathogenesis of ulcerative colitis by regulating SOCS1.
PubMed 2018cited by 16position: middle
Tumor Necrosis Factor Ligand-Related Molecule 1A Regulates the Occurrence of Colitis-Associated Colorectal Cancer
Digestive Diseases and Sciences 2018cited by 7position: middledoi
[The effects of macrophages with high expression of TL1A on activation and proliferation of hepatic stellate cells in vitro].
PubMed 2018cited by 1position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Xiaolan Zhang · Hebei Medical University10 papers (2018–2024)Jinbo Guo · Hebei Medical University7 papers (2018–2024)Fengrong Yin · Hebei Medical University5 papers (2019–2024)Wu Mengyao · Hebei Medical University4 papers (2018–2021)Jia Song · Tianjin University of Science and Technology4 papers (2019–2024)Mingyue Yang · Hebei Medical University3 papers (2018–2020)Hong Zhang · Guangzhou Medical University3 papers (2019–2024)Xiaoxia Huo · Hebei Medical University3 papers (2018–2024)Donglei Sun · Ocean University of China3 papers (2022–2024)Jiawei Shao · Hebei Medical University2 papers (2022–2024)Dong Wang · Center for Cancer Research2 papers (2019–2025)Xiaolan Zhang · China Three Gorges University2 papers (2019–2020)Hong Zhang · Harbin Medical University2 papers (2018–2018)Xiaonan Liang · Xi'an Shiyou University2 papers (2021–2024)Weiwei Niu · Tianjin University2 papers (2018–2024)Guochao Niu · Beijing Founder Electronics (China)2 papers (2019–2021)Rongrong Zhan · Hebei Medical University2 papers (2019–2024)Wenxiu Jia · Hospital of Hebei Province2 papers (2018–2021)Yaxing Kang · University of Science and Technology of China2 papers (2018–2022)Chenyang Li · Hainan University2 papers (2021–2024)